I've lost 3.8 stone on Mounjaro but have had horrid side effects – hair loss & the ‘burning sensation' is just the start
Click to share on Facebook (Opens in new window)
A YOUNG woman has revealed that thanks to Mounjaro, she was able to drop down from over 14 stone to just 10 stone in 28 weeks.
But despite shifting the weight, Chloe Mckernan, 32, who is currently on her 'glow up journey', has experienced a number of horrible side effects.
Sign up for Scottish Sun
newsletter
Sign up
4
A Mounjaro user has candidly opened up on the side effects she has experienced since using fat jabs
Credit: TikTok/@chlo_mckernan
4
Not only has Chloe Mckernan, 32, dealt with a sore scalp, but she's also experienced a "burning sensation" too
Credit: TikTok/@chlo_mckernan
4
Mounjaro is typically used to treat type 2 diabetes
Credit: Getty
Not only has the brunette been battling hair loss and a sore scalp, but she's also been experiencing a strange 'burning sensation' too.
Posting on social media, Chloe, who now has the 'confidence to wear shorts again', revealed that she has lost 3 stone 8 lbs after using Mounjaro, but experts and NHS medics warn about the dangers of taking such medications without a prescription.
The young woman confirmed that as a result of taking Mounjaro, which is regarded by some as the King Kong of weight loss jabs, she has been accused of 'cheating' her weight loss.
But she isn't bothered by what people say, as despite her side effects, she 'feels amazing'.
Sun GP Dr Zoe Williams claimed that Mounjaro, which could soon be rolled out on the NHS, can save the lives of people with 'life-threatening levels of obesity'.
But despite this, the NHS warned: 'Never take an anti-obesity medicine if it has not been prescribed to you.
"These types of medicines may not be safe for you and can cause serious side effects.'
In a recent clip shared online, Chloe revealed the side effects she has had from taking Mounjaro.
She explained: 'Sometimes I feel dizzy when I stand up…always when I've not drunk enough water.
'I can eat most foods but some foods I used to love I can't eat…'
Weight Loss Jabs - Pros vs Cons
Not only this, but she also added: 'My scalp has been really sore recently…I assume this is due to hair loss…
'When I take my dose, the smell of food sometimes makes me sick.'
And that's not all, as she also acknowledged: 'Sometimes my skin feels sore to touch…This is a common side effect for Mounjaro…it's almost like a burning sensation.'
But despite the side effects, Chloe is 'so happy' she started her Mounjaro journey.
She claimed that it hasn't all been negative, as she also now has 'increased energy', no longer battles 'food noise' and has been able to better 'understand portion control' since using the fat jabs.
Everything you need to know about fat jabs
Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases.
Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK.
Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market.
Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year.
How do they work?
The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight.
They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists.
They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high.
Can I get them?
NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics.
Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure.
GPs generally do not prescribe the drugs for weight loss.
Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk.
Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health.
Are there any risks?
Yes – side effects are common but most are relatively mild.
Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea.
Dr Sarah Jarvis, GP and clinical consultant at patient.info, said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.'
Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia.
Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health.
Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines.
Mounjaro users react
Chloe's TikTok clip, which was posted under the username @chlo_mckernan, has clearly left many open-mouthed, as it has quickly racked up 500,500 views.
Not only this, but it's also amassed 8,846 likes, 341 comments and 624 saves.
Numerous other Mounjaro users eagerly flocked to the comments, keen to share the side effects they have experienced whilst using fat jabs.
One person said: 'I have sore skin!!!! And achy legs.'
Shivering, skin sore to touch, being physically sick, back stomach pains, lethargic, light headed
TikTok user
Another added: 'The coldness, I am constantly freezing.'
A third commented: 'My period is the worst period I've ever had in my life.'
Someone else explained: 'The only side effects I've had is being cold a lot and really bad sulphur burps.'
Whilst another woman chimed in: 'I only started on Wednesday, I've been ill! Shivering, skin sore to touch, being physically sick, back stomach pains, lethargic, light headed….'
Fatal consequences
In addition to horrendous side effects, those debating whether to begin using Mounjaro should know that it can also have fatal consequences.
The injections are licensed for patients with type 2 diabetes and are administered every seven days.
4
They are also available to assist those who are clinically obese (with a Body Mass Index of 30 or over).
The drugs, which have been widely regarded as 'fat jabs', can be prescribed by a practitioner - such as a doctor, nurse or a pharmacist-independent prescriber.
But increasingly, we are seeing more and more people buying them through online pharmacies, without sufficient checks.
Not only this, but recently, figures from the Medicines and Healthcare products Regulatory Agency revealed that fat jabs had been linked to 82 deaths across the UK.
Following the death of a man from Burton upon Trent, Staffs, who died after taking Mounjaro, his family are now calling for a probe into the jab's "potential to kill."
Unlock even more award-winning articles as The Sun launches brand new membership programme - Sun Club
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South Wales Argus
2 hours ago
- South Wales Argus
Weight-loss jabs could help obese people control asthma, study suggests
The drugs should be explored as a potential treatment for obese people with the respiratory condition, who are 'often resistant' to steroids, researchers said. Weight-loss jabs, also known as glucagon-like peptide1 receptor-agonists (GLP1-RAs), work by mimicing the hormone GLP-1 to regulate blood sugar and insulin levels. They were initially developed as a treatment for people with type 2 diabetes. A number of types of the drug are recommended to help tackle obesity on the NHS, including semaglutide, or Wegovy, and tirzepatide, or Mounjaro. Previous studies have suggested the drugs may slash the risk of illnesses like dementia and stroke, with an international team of experts exploring their potential impact on obese people with asthma. Professor David Price, University of Aberdeen chair in primary care respiratory medicine, said: 'People with obesity and asthma are unique in that they are often resistant to steroid treatments. 'We know that GLP1s work on inflammatory responses in the airways in a different way to traditionally used steroids.' For the study, published in Advances in Therapy, researchers analysed the records of 10,111 people on GLP1-RAs and 50,555 people who were not on the drugs. After a follow-up period, the team found that those taking weight-loss jabs lost more weight and had improved asthma control. Researchers said the findings suggest medics 'should pay attention to the relationship between GLP-1 RA and the risk of respiratory diseases'. Prof Price added: 'We found compelling evidence that GLP1s, as well as increasing weight loss, also improved asthma symptoms. 'In addition, it is important to note that the benefits to asthma symptoms occurred despite fairly modest weight loss of around 0.9kg over the course of the year. 'Our findings suggest that GLP1s may have beneficial effects on asthma control for people with obesity and this should be explored further.' Prof Alan Kaplan, chairperson of the Family Physician Airways Group of Canada and the Observational and Pragmatic Research Institute, said: 'Our findings suggest that GLP1-RAs have benefits on asthma control in people with obesity, and this information should contribute to the discussions around the decision to use these drugs.' Dr Erika Kennington, head of research and innovation at Asthma and Lung UK, said: 'Research has previously shown that people living with obesity who lose weight see improved control of their asthma, so it's encouraging to see this study show this is still the case when the weight loss is driven by drugs, like the new class of weight loss drugs. 'Although exercise can help people lose weight, for some people it can cause anxiety about becoming breathless or having an asthma attack, so people are stuck in a vicious cycle of not being able to lose weight and their asthma worsening. 'Therefore, where exercise hasn't worked for someone these drugs that support weight loss could offer a promising alternative. 'It's too early to say whether these drugs would be effective for people with asthma more widely. 'More research is needed to understand how these drugs actually improve asthma control. Funding for lung health research is on life support and urgent action is needed to increase investment.'
Daily Mail
2 hours ago
- Daily Mail
ALISON BOSHOFF: Dragon's podcast gives ‘biased and dangerous' advice, says cancer expert
Dragons' Den star Steven Bartlett stands accused of spreading 'dangerous' misinformation on his latest Diary Of A CEO podcast. Bartlett, 32, hosted Dr Roger Seheult, a 'vitamin D expert', who he described as a 'world-leading doctor in internal medicine, lung health, critical care and sleep medicine'. In the trailer for the podcast, already viewed 4.5 million times, Dr Seheult describes a patient who was 'cured', miraculously, 'by sunlight'. Dr Seheult said: 'A 15-year-old boy was diagnosed with blood cancer but he developed a flesh-eating infection in his lung. He wasn't going to make it. So he had one request – to go outside. That's what they did. After the second day, the infection was 60-70 per cent gone. It became clear to me that sunlight has so many health benefits.' He added: 'For example, if you are closer to the window, you are discharged from hospital faster.' Broadcaster and retired surgeon Dr Liz O'Riordan was alarmed by the claims in the trailer. 'This is one of the current problems with podcasts – clips carefully edited to go viral with shocking statements.' She added: 'The clip implies that leaving ITU for sunlight can stop people dying – and yes, it is dangerous. 'The medical information this doctor tells us is second-hand – from the boy's mum, who is not a doctor – and we don't know what made her tell him this. But as a guy pushing sunlight, there will have been some bias in this interview.' (Coincidentally, a link on the podcast's social media offered listeners the chance to buy a sunlight lamp.) Dr O'Riordan, a breast cancer awareness campaigner diagnosed with the disease herself in 2015, said: 'Steven doesn't appear to challenge his guests or ask for the evidence.' She noted the study Dr Seheult mentions, about patients by windows being discharged earlier, was only a small trial, decades ago, of people being treated for bipolar disorder. Meanwhile, on TikTok, a video criticising the Dr Seheult episode of Diary Of A CEO (DOAC) has received more than 15,000 likes. Last year, the BBC World Service broadcast an investigation into Bartlett's podcast – the biggest in the UK, according to Spotify. It flagged that, in one episode, claims by cardiologist Aseem Malhotra that the 'Covid vaccine was a net negative for society' went unchallenged, allowing misinformation to be spread. (In response to the BBC investigation Dr Malhotra said he accepted people disagreed with his views but 'that does not mean that they have been debunked'.) The Lancet medical journal estimates that Covid-19 vaccines saved up to 1.5 million lives. The BBC highlighted other episodes, which aired claims that autism and schizophrenia could be caused by gluten, and that cancer can be 'managed' by food rather than 'medieval' chemotherapy. A spokesperson for Bartlett's production company, FlightStory Studio, said: 'Each guest episode is thoroughly researched prior to commission. DOAC offers guests freedom of expression and believes that progress, growth and learning comes from hearing a range of voices, not just those Steven and the DOAC team agree with.' Dr O'Riordan told me: 'Podcasts like this are a big-money business. The more shocking you can make the story, the more clicks you get. Podcasts are not regulated, people can – and do – say anything they like.' Bartlett said in 2024 he expected to make £20 million that year from his podcast. Adria steps in to ensure it's not the end of the Affair... The Thomas Crown Affair – telling the story of a millionaire who commits heists for the sheer hell of it, and falls for the insurance investigator who is on his tail – is so good they've made it three times. First, of course, was the 1968 classic with Steve McQueen and Faye Dunaway (pictured below) – and soundtrack featuring The Windmills Of Your Mind. Then it was remade in 1999, with Pierce Brosnan alongside Rene Russo. And now comes another reboot with actor, director and producer Michael B. Jordan, who is hot right now thanks to the success of the film Sinners. His version, slated to come out in 2027, started filming in London a couple of weeks ago, but within days the leading lady Taylor Russell stepped away from the movie, with sources saying that there were 'creative differences' between her and Jordan. Luckily, Adria Arjona has leapt into the breach. Arjona, who is stepping out with actor Jason Momoa, appears in the Disney Star Wars spinoff Andor, and also starred in Hit Man with Glenn Powell and Blink Twice with Channing Tatum. Big new role for Barbie star Margot TIM Burton is set to direct Margot Robbie in a remake of the 1958 cult classic Attack Of The 50 ft Woman. The trade papers report that Robbie is going to star in and produce the project, which has been in development at Warner Bros since early 2024. In the movie, an heiress has a close encounter with an alien spacecraft, causing her to grow to the size of a skyscraper. The original starred Allison Hayes, and there was a 1993 TV version which starred Darryl Hannah. Meanwhile, Burton's Wednesday – his series for Netflix about Wednesday Addams – has been commissioned for series 3. The second series comes out next month. $6,000 a ticket, Macca? This had better be good Fans may have been stunned by the price of tickets to see Taylor Swift during her Eras tour – but they ain't seen nothing yet. While some resales to see TayTay ran to $900, the price of seeing Sir Paul McCartney on the US leg of his Got Back tour has reached … $6,308 a head. Tickets went on sale this week and were quickly snapped up, only to appear on resale sites like Viagogo, StubHub and Ticketmaster. Some tickets in Nashville and Pittsburgh are running at more than $6,000 each, with tickets elsewhere ranging between $200 and $1,600. McCartney's management team were not available for comment. But his former publicist Geoff Baker deplored the mess, saying on Facebook: 'The drawback with allowing dynamic pricing at your gigs to raise the cost of a ticket to $1,600 is the huge pressure that you then put on yourself. 'Because if people are paying that much many will expect … not only the best show that they have ever seen, but the best show that you have ever given.' Stephen Mangan met his wife Louise Delamere on the set of a film called Offending Angels. Mangan, who presents The Fortune Hotel on ITV from August 6, said proudly: 'It's the lowest grossing film in British history and made £94 at the box office.' The film, released in 2000, also starred Andrew Lincoln and Jack Davenport. LA sources say that the plastic surgeon's most requested standard of modern beauty is ... Emily Ratajkowski, who plays a super-beautiful influencer in Lena Dunham's hit Netflix comedy Too Much. Apparently everyone wants her cheekbones and jawline. Another satisfied customer! I hear that Olympic diving champ-turned-TV fixture Tom Daley has left the agency YMU, following Claudia Winkleman, Amanda Holden, Emily Atack, Gabby Logan, Rob Rinder, Amelia Dimoldenberg and others out of the door. Football's NOT coming home! Ted Lasso is back – but this time nearly all the filming will be done outside the UK. The popular Apple TV+ show made a bit of a star of the London borough of Richmond, and also filmed around south London. But the latest series is being made mainly in ... Kansas City, where star Jason Sudeikis grew up. (Though it's still set in Richmond.) The new episodes will see Lasso start coaching a women's football team. Hannah Waddingham and Brett Goldstein are among the returning cast.
Rhyl Journal
2 hours ago
- Rhyl Journal
Weight-loss jabs could help obese people control asthma, study suggests
The drugs should be explored as a potential treatment for obese people with the respiratory condition, who are 'often resistant' to steroids, researchers said. Weight-loss jabs, also known as glucagon-like peptide1 receptor-agonists (GLP1-RAs), work by mimicing the hormone GLP-1 to regulate blood sugar and insulin levels. They were initially developed as a treatment for people with type 2 diabetes. A number of types of the drug are recommended to help tackle obesity on the NHS, including semaglutide, or Wegovy, and tirzepatide, or Mounjaro. Previous studies have suggested the drugs may slash the risk of illnesses like dementia and stroke, with an international team of experts exploring their potential impact on obese people with asthma. Professor David Price, University of Aberdeen chair in primary care respiratory medicine, said: 'People with obesity and asthma are unique in that they are often resistant to steroid treatments. 'We know that GLP1s work on inflammatory responses in the airways in a different way to traditionally used steroids.' For the study, published in Advances in Therapy, researchers analysed the records of 10,111 people on GLP1-RAs and 50,555 people who were not on the drugs. After a follow-up period, the team found that those taking weight-loss jabs lost more weight and had improved asthma control. Researchers said the findings suggest medics 'should pay attention to the relationship between GLP-1 RA and the risk of respiratory diseases'. Prof Price added: 'We found compelling evidence that GLP1s, as well as increasing weight loss, also improved asthma symptoms. 'In addition, it is important to note that the benefits to asthma symptoms occurred despite fairly modest weight loss of around 0.9kg over the course of the year. 'Our findings suggest that GLP1s may have beneficial effects on asthma control for people with obesity and this should be explored further.' Prof Alan Kaplan, chairperson of the Family Physician Airways Group of Canada and the Observational and Pragmatic Research Institute, said: 'Our findings suggest that GLP1-RAs have benefits on asthma control in people with obesity, and this information should contribute to the discussions around the decision to use these drugs.' Dr Erika Kennington, head of research and innovation at Asthma and Lung UK, said: 'Research has previously shown that people living with obesity who lose weight see improved control of their asthma, so it's encouraging to see this study show this is still the case when the weight loss is driven by drugs, like the new class of weight loss drugs. 'Although exercise can help people lose weight, for some people it can cause anxiety about becoming breathless or having an asthma attack, so people are stuck in a vicious cycle of not being able to lose weight and their asthma worsening. 'Therefore, where exercise hasn't worked for someone these drugs that support weight loss could offer a promising alternative. 'It's too early to say whether these drugs would be effective for people with asthma more widely. 'More research is needed to understand how these drugs actually improve asthma control. Funding for lung health research is on life support and urgent action is needed to increase investment.'
